SARTORIUS AG (SRT.DE) Stock Price & Overview

FRA:SRT • DE0007165607

180.8 EUR
-5 (-2.69%)
Last: Mar 5, 2026, 05:29 PM

The current stock price of SRT.DE is 180.8 EUR. Today SRT.DE is down by -2.69%. In the past month the price decreased by -3.93%. In the past year, price decreased by -1.53%.

SRT.DE Key Statistics

52-Week Range131.4 - 208
Current SRT.DE stock price positioned within its 52-week range.
1-Month Range177.4 - 198.6
Current SRT.DE stock price positioned within its 1-month range.
Market Cap
13.538B
P/E
37.82
Fwd P/E
29.88
EPS (TTM)
4.78
Dividend Yield
0.38%

SRT.DE Stock Performance

Today
-2.69%
1 Week
-4.94%
1 Month
-3.93%
3 Months
-8.13%
Longer-term
6 Months +14.43%
1 Year -1.53%
2 Years -34.25%
3 Years -43.06%
5 Years -51.14%
10 Years -38.70%

SRT.DE Stock Chart

SARTORIUS AG / SRT Daily stock chart

SRT.DE Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to SRT.DE. When comparing the yearly performance of all stocks, SRT.DE is a bad performer in the overall market: 79.35% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
SRT.DE Full Technical Analysis Report

SRT.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to SRT.DE. SRT.DE may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
SRT.DE Full Fundamental Analysis Report

SRT.DE Earnings

On February 3, 2026 SRT.DE reported an EPS of 1.26 and a revenue of 927.60M. The company beat EPS expectations (7.55% surprise) and beat revenue expectations (0.24% surprise).

Next Earnings DateApr 23, 2026
Last Earnings DateFeb 3, 2026
PeriodQ4 / 2025
EPS Reported€1.26
Revenue Reported927.6M
EPS Surprise 7.55%
Revenue Surprise 0.24%
SRT.DE Earnings History

SRT.DE Forecast & Estimates

8 analysts have analysed SRT.DE and the average price target is 304.73 EUR. This implies a price increase of 68.54% is expected in the next year compared to the current price of 180.8.

For the next year, analysts expect an EPS growth of 26.59% and a revenue growth 7.13% for SRT.DE


Analysts
Analysts80
Price Target304.73 (68.55%)
EPS Next Y26.59%
Revenue Next Year7.13%
SRT.DE Forecast & Estimates

SRT.DE Groups

Sector & Classification

SRT.DE Financial Highlights

Over the last trailing twelve months SRT.DE reported a non-GAAP Earnings per Share(EPS) of 4.78.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)133.70M
Industry RankSector Rank
PM (TTM) 3.8%
ROA 1.39%
ROE 5.01%
Debt/Equity 1.28
Chartmill High Growth Momentum
EPS Q2Q%21.15%
Sales Q2Q%2.29%
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A
SRT.DE financials

SRT.DE Ownership

Ownership
Inst Owners4.42%
Shares74.88M
Float1.63M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
SRT.DE Ownership

SRT.DE Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
SRT3 SARTORIUS AG-VORZUG37.2317.365B
DIM SARTORIUS STEDIM BIOTECH31.8817.008B
56S1 SARTORIUS STEDIM BIOTECH32.7216.994B
QIA QIAGEN N.V.17.548.42B
1SXP SCHOTT PHARMA AG& CO KGAA12.492.151B
EVT EVOTEC SE N/A2.007B
GXI GERRESHEIMER AG5.94592.361M
FF FINE FOODS & PHARMACEUTICALS15.88241.557M
ALECR EUROFINS CEREP-REGR N/A164M
MLC MALIN CORP PLC N/A

About SRT.DE

Company Profile

SRT logo image Sartorius AG is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Goettingen, Niedersachsen. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. The company operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.

Company Info

SARTORIUS AG

Otto-Brenner-Str. 20

Goettingen NIEDERSACHSEN DE

Employees: 13573

SRT Company Website

Phone: 495513080

SARTORIUS AG / SRT.DE FAQ

What does SARTORIUS AG do?

Sartorius AG is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Goettingen, Niedersachsen. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. The company operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.


What is the stock price of SARTORIUS AG today?

The current stock price of SRT.DE is 180.8 EUR. The price decreased by -2.69% in the last trading session.


Does SARTORIUS AG pay dividends?

SARTORIUS AG (SRT.DE) has a dividend yield of 0.38%. The yearly dividend amount is currently 0.74.


What is the ChartMill rating of SARTORIUS AG stock?

SRT.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


On which exchange is SRT.DE stock listed?

SRT.DE stock is listed on the Frankfurt Stock Exchange exchange.


What is SARTORIUS AG worth?

SARTORIUS AG (SRT.DE) has a market capitalization of 13.54B EUR. This makes SRT.DE a Large Cap stock.